Published in Gene Therapy Weekly, July 18th, 2002
Respiratory syncytial virus (RSV) is most often recognized for causing severe pulmonary illness, including bronchitis and pneumonia, in young children, and mild or no pulmonary symptoms in adults. Medical investigators are now saying that RSV could provide a vehicle for transporting therapeutic genes to cells in the lungs while causing little harm to the treated patient.
Researchers at the University of North...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.